Structure Therapeutics
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Structure Therapeutics generated cash of -$79,488,000, which is less than the previous year. Cash used in financing activities reached the amount of $451,531,000 last year. Net change in cash is therefore $103,701,000.
Cash Flow
| 2020 | -14.28K | -21.14K | 25.83K |
|---|---|---|---|
| 2021 | -32.16K | 17.85K | 103.25K |
| 2022 | -46.12M | -62.10M | 29.01M |
| 2023 | -79.48M | -268.34M | 451.53M |
GPCR Cash Flow Statement (2020 – 2023)
| 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|
Cash at beginning of period | 26.09M | 105.30M | 16.35K | 25.94K |
Operating activities | ||||
Net income | -89.62M | -51.32M | -38.04K | -15.87K |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||
Depreciation and amortization | 295K | 277K | 72 | 20.03K |
Stock-based compensation expense | 8.19M | 2.51M | 1.48M | 570K |
| Deferred income tax benefit | 8.19M | 2.51M | 1.48M | 570K |
| Changes in operating assets and liabilities: | ||||
Accounts receivable, net | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 |
Accounts payable | -859.25K | 2.15M | 1.89K | 1.02K |
Cash generated by operating activities | -79.48M | -46.12M | -32.16K | -14.28K |
Investing activities | ||||
Purchases Of Investments | -416.99M | -123.45M | -4.21K | -21.12K |
Investments In Property Plant And Equipment | -2.16M | -155K | -1.20K | -19 |
Acquisitions Net | 0 | 61.95K | -19.06K | 0 |
Cash generated by investing activities | -268.34M | -62.10M | 17.85K | -21.14K |
Financing activities | ||||
Common Stock Issued | 472.29M | 0 | 103.39M | 25.88M |
Payments for dividends | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | -6K | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 |
Cash used in financing activities | 451.53M | 29.01M | 103.25K | 25.83K |
Net Change In Cash | 103.70M | -79.21M | 88.95K | -9.59K |
Cash at end of period | 129.79M | 26.09M | 105.30K | 16.35K |
| Data source | Data source |